Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)
Conditions: Hyperactivity in Children With Down Syndrome; Impulsivity in Children With Down Syndrome Interventions: Drug: Guanfacine Hydrochloride Immediate Release; Drug: Placebo Sponsors: Rachel G. Greenberg, MD, MB, MHS; The Emmes Company, LLC; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials